Cadre Holdings (CDRE) Q1 2026: Backlog Surges $166M as Defense and Nuclear Tailwinds Accelerate

Cadre Holdings entered 2026 with a record $355 million backlog, up $166 million sequentially, reflecting robust demand across law enforcement, military, and nuclear safety markets. Strategic M&A and disciplined capital allocation remain central, with recent acquisitions expanding both product range and recurring revenue base. Management reaffirmed guidance and signaled confidence in margin expansion and continued growth, even as distribution softness and shifting government budgets require close monitoring.

Summary

  • Backlog Expansion Signals Demand Visibility: Record orders backlog and organic growth reinforce multi-year sales momentum.
  • M&A Execution Broadens Platform: Recent acquisitions strengthen vertical integration and recurring revenue streams.
  • Margin Improvement Expected in H2: Mix normalization and operating leverage set up for back-half profitability gains.

Business Overview

Cadre Holdings is a diversified provider of mission-critical safety and survivability equipment, serving law enforcement, first responders, military, and nuclear markets. The company generates revenue through the sale of proprietary products—such as armor, duty gear, and nuclear safety systems—as well as distribution of third-party safety equipment. Its business is organized around public safety (law enforcement, military) and nuclear safety, with a growing focus on recurring revenue from consumables and aftermarket support.

Performance Analysis

Cadre delivered 19% year-over-year sales growth in Q1 2026, driven by both organic demand and recent acquisitions. The standout operational highlight was a record $355 million backlog, up $166 million from the prior quarter, fueled by an $87 million blast attenuation contract and strong organic orders in armor and duty gear. The Tier Tactical acquisition contributed $57 million to backlog, while Alien Gear Holsters, acquired in April, expands the company’s consumer and direct-to-consumer reach.

Margins were in line with expectations, though management flagged temporary headwinds from product mix in armor and nuclear segments, with improvement expected as the year progresses and larger, higher-margin orders ship. The distribution segment saw softness in discretionary third-party products, but Cadre-branded products remained resilient. Organic growth guidance remains at 3% to 5% for the full year, with H2 expected to be back-end loaded due to shipment timing and contract conversion.

  • Backlog Growth Outpaces Revenue: The $108 million organic backlog increase, plus $57 million from Tier, signals strong forward visibility.
  • Acquisition Pipeline Remains Robust: Over $400 million deployed in M&A since 2024, with disciplined focus on recurring revenue and defensible market positions.
  • Distribution Segment Monitored for Softness: Discretionary third-party sales lagged, but core Cadre products maintained demand resilience.

With stable free cash flow and a manageable leverage profile, Cadre is positioned to fund both organic investments and further M&A, while returning capital through dividends.

Executive Commentary

"We ended the first quarter with record orders backlog of $355 million, which included $108 million of organic increase from Q4 to Q1. Brad and Blaine will provide additional details on the backlog, but its substantial growth signals strong demand as we progress through the remainder of the year."

Warren Kanders, Chairman & CEO

"Margins were in line with expectations in Q1. We knew coming into the quarter we had some mixed headwind in armor and nuclear that was driven by the complexion of our backlog. Right now, we expect margins to improve as we move through the year, which is a function of improving mix and leverage on increasing revenues."

Blaine Browers, Chief Financial Officer

Strategic Positioning

1. Backlog as Leading Indicator

The record $355 million backlog, up $166 million sequentially, is a powerful forward indicator, providing multi-quarter revenue visibility and supporting management’s confidence in guidance. The backlog is diversified, with a significant portion shippable in 2026, excluding the multi-year blast attenuation contract that extends visibility into 2027.

2. M&A as Growth Engine

Disciplined acquisitions remain central to Cadre’s strategy. The company targets assets with strong margins, recurring revenue, and strategic fit. The Tier Tactical acquisition (platform, $175 million) and Alien Gear Holsters (bolt-on, $10 million) broaden the product portfolio and deepen direct-to-consumer channels. Management sees further opportunity, especially in nuclear safety and public safety verticals.

3. Margin Expansion and Operating Leverage

Despite Q1 mix headwinds, Cadre expects margin improvement in the second half, driven by higher-margin shipments and operating leverage as volumes ramp. The company’s recurring revenue streams and focus on mission-critical products create resilience even in volatile macro environments.

4. Capital Allocation Discipline

Management reiterated a balanced capital allocation approach, prioritizing M&A, organic investments, and shareholder returns via dividends. The company’s leverage target remains around 2x, with free cash flow directed toward both debt reduction and opportunistic acquisitions.

5. End-Market Diversification

Cadre’s exposure to both public safety and nuclear safety markets provides a hedge against cyclicality. Shifting government budgets and global defense spending trends are being closely tracked, with management positioning to capture upside from defense modernization and energy security initiatives.

Key Considerations

Cadre’s Q1 sets a foundation for a record 2026, but the evolving market landscape and operational execution must be monitored closely.

Key Considerations:

  • Backlog Conversion Timing: The majority of the backlog is expected to convert within the year, but large contracts like the blast attenuation seat award will extend into 2027, affecting revenue cadence.
  • Distribution Channel Volatility: Company-owned distribution saw softness in discretionary third-party products, suggesting potential vulnerability if budget headwinds at state and local levels persist.
  • Margin Sensitivity to Mix: Armor and nuclear mix drove Q1 margin headwinds, but H2 shipments of higher-margin products are expected to restore profitability trajectory.
  • M&A Integration and Synergy Realization: Ongoing integration of Tier and Alien Gear will be critical to achieving planned cross-selling and operational synergies.
  • Government Budget Shifts: DOE budget changes could impact nuclear segment demand, but defense-related spending is set to benefit Cadre’s core offerings.

Risks

Key risks include: persistent softness in discretionary distribution sales, potential delays in government contract conversion, and integration challenges with recent acquisitions. Shifting U.S. and international government budgets could alter demand patterns, especially in nuclear and public safety. While Cadre’s core products have historically been budget priorities, any prolonged downturn in state or local funding or unexpected geopolitical shifts could pressure near-term results.

Forward Outlook

For Q2 2026, Cadre guided to:

  • Revenue of approximately $178 million
  • Adjusted EBITDA margin around 17.5%

For full-year 2026, management reaffirmed guidance:

  • Net sales of $736 million to $758 million
  • Adjusted EBITDA of $136 million to $141 million (18.5% margin midpoint)
  • Organic revenue growth of 3% to 5%

Management highlighted several factors that support the outlook:

  • Strong backlog conversion expected in H2, especially for armor and duty gear
  • Further M&A anticipated, with a robust pipeline and financial flexibility

Takeaways

Cadre’s Q1 performance underscores its multi-year growth trajectory, with record backlog and disciplined capital deployment positioning the company for continued expansion.

  • Backlog Depth Provides Revenue Visibility: The $355 million backlog, with broad-based organic and inorganic contributions, underpins confidence in 2026 and beyond.
  • M&A Remains a Growth Catalyst: Recent deals expand the portfolio and recurring revenue, but successful integration and synergy capture will be key to value realization.
  • Margin and Mix Improvement Will Be H2 Drivers: Investors should watch for margin expansion as higher-margin orders ship and distribution channel volatility stabilizes.

Conclusion

Cadre Holdings enters the remainder of 2026 with record backlog and a robust pipeline, reinforcing its position as a mission-critical supplier to durable end markets. Execution on backlog conversion, M&A integration, and margin recovery will determine the company’s ability to sustain its growth and capital return commitments.

Industry Read-Through

Cadre’s results highlight the resilience and secular growth in mission-critical safety and defense markets, even as budgetary and macro challenges persist. Backlog growth and M&A-driven platform expansion set a template for other safety, defense, and nuclear suppliers seeking to diversify revenue streams and build recurring business models. Shifts in U.S. and global government spending priorities, especially toward defense and nuclear energy, are likely to benefit peers with similar product portfolios and end-market exposures. Distribution channel volatility may be an early warning for other suppliers reliant on discretionary municipal spending.